Boletín semanal de ofertas de empleo publico
FPU Predoctoral Candidates - Breast Cancer Resilience
We seek for an excellent and highly motivated students that are willing to apply for an FPU 2017 predoctoral fellowship (DEADLINE 22 JANUARY 2017)
Job position description:
The following requisites apply to all candidates:
1- Degree in any life science, including mathematics or statistics.
2- Excellent academic degree record; first-class honors (score >2.5 of 4).
3- Two reference contacts, including a degree professor and master or experimental advisor.
4- Any nationality but fluent English is mandatory.
5- Self-motivated, independent, enthusiastic with science, and team worker.
The candidate will enroll the Breast Cancer and Systems Biology research lab at the Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL). The group is part of a newly created Research Program Against Cancer Therapeutic Resistance (ProCURE). The overall aim of the research group is to better understand breast cancer development, the emergence of subtypes, and their therapeutic response/resistance. Importantly, the group combines experimental and bioinformatic expertise towards these fundamental questions. Currently, the group is constituted by two postdocs, a predoctoral student and a research technician, and maintains several key national and international collaborations in the depicted field.
Candidates should send a CV, a motivation letter and references to Dr. Miguel Angel Pujana (email@example.com)
Información complementaria de la oferta:
The study of the genetic basis of hereditary cancer has been commonly focused on understanding molecular perturbations in affected individuals. Thus, many genetic risk factors have been discovered in the past years. However, understanding why individuals at high risk (i.e. carriers of germline mutations with large effects) do not develop cancer remains an unexplored fundamental subject. The identification of strongly protective alleles or mutations for specific cancer syndromes, such as of breast and ovarian cancer, will revolutionize cancer prevention and treatment. Here, we propose a multidisciplinary research project aimed at identifying such mutations and genes.